Study Of The Impact Of Inlyta In 2nd Line On The Treatment Outcomes Of mRCC Patients Treated With Sutent In 1st Line In The Real Life Setting
Clinical trial NCT02184416 · COMPLETED
Trial details
- NCT number
- NCT02184416
- Sponsor
- Pfizer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2014-10-31
- Primary completion
- 2022-09-30
- Enrollment
- 554
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.